On the stock market since 2009, it operates in the world of health and science. It has 2,965 employees. Now — the numbers.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Bets Against the Stock: The number of investors betting on a fall stands out.
The stock trades 34% below its peak. The market has trimmed its expectations for the company.
It pays out $0.02 per share each year — regular cash for whoever holds the stock.
The stock sits at $0.67. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The weight of investors positioned for a fall can be felt in the market. Council score: 2/10.
The sales tempo runs behind the sector. Council score: 4/10.
On our five-subject report card, RAFLF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: RAFLF is a high-risk stock — not yet profitable, and its future rides on its product catching on.